In this study, we present an algorithm for three-dimensional ͑3-D͒ dose reconstruction using portal images obtained with an electronic portal imaging device ͑EPID͒. For this purpose an algorithm for 2-D dose reconstruction, which was previously developed in our institution, was adapted. The external contour of the patient was used to correct for absorption of primary photons, but the presence of inhomogeneities was not taken into account. The accuracy of the algorithm was determined by irradiating two anthropomorphic breast phantoms with 6 MV photons. The dose values derived from portal images were compared with results from 3-D dose calculations, which, in turn, were verified with data obtained with an ionization chamber and film dosimetry. It was found that the application of contour information significantly improves the accuracy of 2-D dose reconstruction. If the total dose at the isocenter plane resulting from all treatment beams is reconstructed, the average deviation from the planned dose is 0.1%Ϯ1.7% ͑1 SD͒. If contour information is not available, the differences increase up to Ϯ20% for the individual beams. In that case, the dose can only be reconstructed with reasonable accuracy when ͑nearly͒ opposing beams are used. The average deviation of the 3-D reconstructed dose from the planned dose in the irradiated volume is 1.4%Ϯ5.4% ͑1 SD͒. If the irradiated volume is enclosed by planes less than 5 cm distant from the isocenter plane, then the average deviation is only 0.5%Ϯ3.4% ͑1 SD͒. It can be concluded that the proposed algorithm for a 3-D dose reconstruction allows a determination of the dose at the isocenter plane and the dose-volume histogram with an accuracy acceptable for an independent verification of the treatment.
I. INTRODUCTION
Portal ͑transit͒ dosimetry, using electronic portal imaging devices ͑EPIDs͒, is a technique where dose measurements made behind a patient are used to verify the dose delivered to that patient. Several classes of portal dosimetry methods have been developed, which can be divided in two main categories. The first group, which can be defined as class ͑a͒ solutions, uses planning CT data, the prescribed number of monitor units, and information concerning the beam setup to predict the dose at the level of the EPID, and compares the measured and predicted dose distributions. [1] [2] [3] [4] By adapting the primary energy fluence in an iterative way, the dose distribution at the position of the EPID can then be recalculated until agreement with the measured dose distribution is obtained. 2, 3 In this way the actual dose delivered to a patient can be reconstructed from EPID images. The second category consists of techniques that back-project the EPID dose distribution to the patient level, either at the exit plane, or at the midplane, or through the whole irradiated volume. The differences between these back-projection methods are mainly related to the amount of knowledge about the patient anatomy that is used during the back-projection stage. In our institution, methods have been developed that are based on rather simplifying assumptions about the patient anatomy ͑class b͒, such as symmetry of the irradiated part of the body. 5, 6 Other groups have used planning CT scans to derive the dose in a specific plane ͑class c͒. 7, 8 The most advanced approaches apply on-line acquired CT data to compute the actual treatment-time dose distribution using various sophisticated algorithms ͑class d͒. 9, 10 The validity of these approaches mainly depends on the type of errors that may occur and should be traced by portal dosimetry, as well as on the availability of planning or online CT data. Because portal dosimetry is generally used as independent verification of the treatment ͑similar to an independent monitor unit calculation͒, its accuracy does not need to be as high as the dose calculation performed by the clinically applied treatment planning system. The accuracy of the portal dosimetry procedure determines the magnitude of errors that can be detected. The following types of errors may potentially be detected by portal dosimetry: ͑1͒ machine output, field flatness, or intensity modulation errors; ͑2͒ errors in monitor unit calculations; ͑3͒ patient setup errors; ͑4͒ errors due to patient shape changes and organ motion. Machine output errors are detected by all methods. Methods in class ͑a͒ are insensitive to errors in the monitor unit calculations because the same number of MUs is used for the measurement and calculation of the portal dose images. 8 Methods in classes ͑a͒, ͑b͒, and ͑c͒ are, in principle, insensitive to dosimetric errors caused by patient setup errors in the beam direction. Consequently, these methods should be combined with a geometrical verification protocol, preferentially based on an orthogonal set of EPID images, to minimize the influence of patient setup errors. Only the class ͑d͒ methods can detect organ motion and patient deformation and allow a complete dosimetric ͑and geometric͒ verification. With methods in classes ͑a͒-͑c͒ the source of a deviation between the planned and measured dose may not always be clear. For instance, weight loss of the patient may cause similar dosimetric deviations as a machine error. For this reason, clinical protocols need to be devised on how to handle observed errors, for instance, including a rescan of the patient. Planning CT data are not always available, and on-line CT data is currently only available to a few centers. We therefore adapted our class ͑b͒ portal dosimetry method to achieve a semiclass ͑c͒ or class ͑d͒ application by including only external patient contour data, which may be acquired during simulation ͑class c͒ or during treatment ͑class d͒. Such an adapted algorithm can also be applied if CT data are available. The advantage of including more patient data is that treatment verification becomes more reliable in those cases that the dose calculation algorithm was inaccurate ͑large contour variations, inhomogeneities͒. Clearly, the drawback of including pretreatment patient contour data in the verification system is that the sensitivity for dosimetric deviations due to contour changes is reduced and the advantages and disadvantages should therefore be carefully weighted.
In breast radiotherapy, portal dosimetry is applied either to improve dose homogeneity in the irradiated volume [11] [12] [13] [14] [15] [16] [17] or to verify the dose delivery. 18, 19 Improvement of dose homogeneity may be achieved by applying portal dosimetry to design either compensators or intensity-modulated radiotherapy ͑IMRT͒ fields for individual patients. In our institution, the application of IMRT is planned for breast cancer patients with the main goal the reduction of the dose to the heart. 20, 21 Criteria for selecting patients, who would benefit most from IMRT, are currently being developed in treatment planning studies. 21, 22 Portal dosimetry may then be used to estimate the dose delivered to the heart. However, a comparison of patient dose distributions ͑or its derivatives, e.g., dose-volume histograms͒, which have been reconstructed from portal images, with those obtained from the treatment planning system, is not straightforward.
In many institutions, the dose distribution is calculated only in a single plane during treatment planning of breast cancer patients. The patient contour is measured during the simulator session in a plane through the isocenter perpendicular to the long axis of the patient. Subsequently, the dose distribution in that plane is calculated using a treatment planning system, maximizing the uniformity of the dose distribution by beam weight optimization, and determining the number of monitor units of the treatment beams.
For these breast cancer patients, the planes used for the dose reconstruction from portal images do not correspond with the plane used for treatment planning. In portal dosimetry, the dose is generally reconstructed in the isocenter plane, i.e., the plane through the isocenter perpendicular to the direction of the treatment beam. 5, [23] [24] [25] However, if the patient contour and/or the ͑electron͒ density distribution within the patient are not symmetric with respect to the isocenter plane, the dose will be reconstructed in the radiological midplane. The radiological midplane is, in fact, a surface that connects those points of the rays emerging from the radiation source in the direction of the portal imager that have an equal transmission within the patient at either side of that ray. For breast cancer patients in particular, the isocenter plane and radiological midplane do not coincide, as is shown schematically in Fig. 1͑a͒ ; the radiological midplane is curved and does not always include the isocenter. Our first aim in this study was to modify the original reconstruction algorithm to enable dose reconstruction at the isocenter plane by incorporating patient contour data. Next, the accuracy of the dose reconstruction using the modified algorithm was assessed by a comparison with film and a treatment planning system ͑see Sec. II F͒. The accuracy of the original algorithm has been previously investigated for various geometries. 5, 6, [23] [24] [25] In particular, for configurations representative for pelvic treatments, the dose could be determined from EPID images with a maximum deviation of about 2% from the actual dose. The accuracy decreases when the tissue density distribution is inhomogeneous and/or asymmetrically distributed, especially if CT data is not used. The accuracy of dose reconstruction was also not yet assessed for breast cancer treatment. In addition to complicating factors such as the asymmetry of the patient contour and the presence of lungs, the accuracy of dose reconstruction for this patient group may be further decreased due to the relatively small distance between the patient and the portal imager. This air gap must be relatively small to allow imaging of the largest treatment fields. Consequently, the contribution of scatter from the patient to the portal imager will be larger and less homogeneous than accounted for in the original algorithm. Therefore, a more accurate correction for the scatter contribution from the patient to the portal imager has to be considered as well.
Pretreatment verification using phantoms is currently the only way to verify dose delivery using 3-D conformal or IMRT techniques. It will, however, be very reassuring if also the actual dose delivered by these sophisticated techniques to patients could be verified. In addition to a more general and more accurate 2-D dose delivery validation, 3-D verification of the patient dose using portal images would be very useful. Especially in the absence of CT data, and for those patients whose dose is only calculated in one plane during treatment planning, 3-D dose reconstruction may prove to be a valuable tool to assess the dose delivery. Our second purpose of this study was therefore to extend the existing 2-D dose reconstruction algorithm and to test the accuracy of 3-D dose reconstruction.
II. MATERIALS AND METHODS

A. 2-D dose reconstruction
We modified the original algorithm 6 to include contour information, but also other modifications have been made. The steps of the modified reconstruction algorithm are described below. The portal images of the treatment beams acquired with and without patient ͑the latter will be called ''open images''͒ are used as input for the reconstruction algorithm. In the first step, the measured pixel values I exp of both images are multiplied with a sensitivity matrix S i j to correct for the differences in gain and offset values of the individual pixels. In this equation also the calibration applied to the raw pixel values is described: 
The third step consists of a deconvolution of D EPID with a 2-D scatter kernel K EPID to correct for the lateral scatter within the plane of the imager:
in which
where C 1 is a calibration constant, r is the distance to the origin, and is the linear attenuation coefficient of water. In the fourth step, the transmission T, through the patient, is estimated by the ratio of the patient and open portal dose values. Those pixels where the transmission is less than one ͑for practical reasons, we use less than 0.9͒ correspond with tissue in the patient, and are set to 1 in image ⌫; all other pixels are set to 0. The product of ⌫ and the portal dose is then convolved with a 2-D scatter kernel K pat to estimate the contribution of patient scatter to the portal dose image, S pat→EPID :
This scatter contribution is subtracted from the portal dose image to determine the primary dose at the portal imager and the transmission through the patient is subsequently recalculated as the ratio of the primary and open portal dose. In the next step, the primary dose at the midplane of the patient is calculated using the inverse square law and a correction for the attenuation of the photon beam ͑see further below͒. To calculate the contribution of scattered radiation to the total midplane patient dose, the primary dose at the midplane is weighted with the normalized scatter-to-primary ratio, NSPR, which is a polynomial fit function depending on the recalculated transmission T 6 and subsequently convolved with another 2-D scatter kernel. Finally, the estimated scatter is added to the primary dose to yield the total patient midplane dose:
The sensitivity matrix, the calibration constants, and the fit parameters for the NSPR and scatter kernels are determined for each EPID-treatment beam combination for all clinically relevant field sizes from a series of experiments in which a set of polystyrene slabs with various thickness is applied.
In the original algorithm, the midplane dose was determined indirectly, by first calculating the exit dose, which was subsequently converted to the midplane dose. 6 For this conversion, the inverse square law ͑ISQL͒ and a correction for the attenuation between the exit point and the midplane were applied to calculate the primary dose at the midplane. For the latter correction, it was assumed that the radiological midplane coincides with the isocenter plane. However, the ISQL and attenuation correction may refer to different planes: the isocenter plane and radiological midplane, respectively. For prostate treatments, these planes will, more or less, coincide, but for breast patients a significant error may be introduced, as shown in Fig. 1͑a͒ . Furthermore, the conversion of exit to midplane dose introduces additional data ͑and corresponding uncertainties͒ and is redundant, since the fit parameters in the reconstruction algorithm can be optimized for direct midplane dose reconstruction. For these reasons, the original algorithm was adapted to explicitly distinguish between dose reconstruction in the isocenter plane ͑i.e., with attenuation correction͒ or in the radiological midplane ͑i.e., without attenuation correction͒.
For simple configurations ͑e.g., if the radiological midplane and isocenter plane coincide͒, the dose at the isocenter plane can be reconstructed without the application of additional data. In that case, the primary portal dose image is scaled using the ISQL and ͱ T to calculate the primary dose at the isocenter plane. If this calculation would be used for asymmetric configurations, the primary dose would be approximately reconstructed at the radiological midplane. To calculate the primary dose at the isocenter plane, 3-D contour data are required to correct for the difference in attenuation of the treatment beam in the volume proximal to and distal from the isocenter plane. The scaling factor ͱ T is then replaced by a single exponential function: exp(Ϫ•x), where and x represent the linear mass attenuation coefficient of water for a specific beam quality and the geometrical path length along a ray through the patient from the isocenter plane up to the exit surface, respectively. To compare the accuracy of both reconstruction algorithms, the patient dose was reconstructed both with and without the attenuation correction. At this stage of our study, the presence of lung tissue and bony anatomy is not taken into account, and is the topic of future work to extend the application of the algorithm to sites including these tissues.
B. 3-D dose reconstruction
An important new application of the modified algorithm is its ability to reconstruct the dose in three dimensions. To test the feasibility of this technique with the existing software, the patient dose was reconstructed in various planes. For the calculation of the primary dose at each reconstruction plane, the appropriate ISQL and attenuation correction, based on the external patient contour, are applied. Currently, the scatter kernel is taken independently of the depth of the reconstruction plane to limit the number of experiments required for the determination of the fit parameters. Because the lateral and medial beams are not exactly opposing, the planes at which the patient dose is reconstructed do not coincide. Therefore, the reconstructed dose distributions of the individual beams are geometrically projected on the plane bisecting the individual planes ͓Fig. 1͑c͔͒. Subsequently, these dose distributions are added to calculate the total dose. In this way the error, which would be introduced if two noncoplanar dose distributions were directly added, is circumvented. A small error still may persist since the dose distributions are assumed to be invariant under projection.
27
C. Portal imaging
A Varian-MARK I-type detector ͑Varian Inc., Palo Alto, CA͒ was applied for portal imaging in this study. This detector has a sensitive area of 32ϫ32 cm 2 and an image is acquired in 5.2 s. A polystyrene build-up layer of 8 mm was placed on top of the EPID to obtain electron equilibrium at the position of the liquid of the ionization chambers in the experiments using 6 MV photon beams. The source-detector distance is equal to 145 cm, a distance at which for most breast treatments the complete treatment field could be imaged. For each beam, open images and images made with an anthropomorphic phantom were acquired. The dose distribution in the phantom was reconstructed from these images using the algorithm described in the previous sections. 24, 25 
D. Beam setup and dose determination for the anthropomorphic phantoms
Two anthropomorphic phantoms were irradiated using 6 MV photon beams generated with an Elekta SL15 linear accelerator applying the standard treatment technique used for breast cancer patients in our clinic. This technique encompasses two nearly opposing tangential treatment fields, each consisting of an open and a wedged beam using a 60°mo-torized wedge. The individual beams are designated as medial-open, medial-wedged, lateral-open, and lateralwedged, respectively. The anthropomorphic phantoms have a geometry based on patient CT data as previously described 28 and consist of polystyrene and cork, the latter being used as replacement for the lungs. Depending on the type of phantom, radiographic films can be positioned in sagittal ͑phan-tom A͒ or transversal ͑phantom B͒ planes ͑Fig. 1͒. The lateral displacement from the isocenter of the radiographic films in phantom A was Ϫ4.5, Ϫ1.5, and ϩ1 cm, respectively ͓Fig. 1͑a͔͒. In phantom B, the radiographic films were placed at Ϫ5.5, Ϫ0.5 or ϩ0.5, and ϩ4.5 cm from the iso-center, respectively ͓Fig. 1͑b͔͒. The absolute dose at the isocenter of phantom B could be measured by positioning a calibrated Farmer-type ionization chamber ͑NE Technology Limited, NE2571͒ in a hole drilled in a slab of polystyrene. The charge was measured with a Keithley, K3 electrometer. Because phantom A has been glued together, we decided not to drill a hole for the placement of an ionization chamber. The beam configurations for the two phantoms were identical, but the isocenter position was slightly different in the two phantoms; more lung was irradiated in phantom A compared to phantom B, resulting in small differences in the dose distributions in the two phantoms.
Treatment planning was performed using Pinnacle ͑ADAC/Philips͒ release 5.2g, applying the collapsed cone superposition/convolution algorithm. Radiographic films were positioned in the anthropomorphic phantoms during CT scanning to assure an identical phantom geometry as during irradiation. Since the elemental composition of cork is not known, the relative electron density of cork in the anthropomorphic phantom was set to 0.25. To trace inaccuracies in the reconstruction algorithm, which are specific for a particular treatment beam ͑e.g., due to the application of wedges͒, the dose distributions of all beams were determined separately, both experimentally and with the TPS.
E. Film dosimetry
Sensitometric curves of the radiographic films ͑KODAK X-OMAT V͒ were obtained by irradiating seven films with varying exposures, ranging between 0-120 monitor units ͑MUs͒, using a field size of 10ϫ10 cm 2 . These calibration films were placed at 10 cm depth in a phantom consisting of ten polystyrene slabs with a total thickness of 20 cm. The absolute dose at the position of these films was measured using a calibrated Farmer-type ionization chamber. Each measurement was repeated at least once to check the reproducibility of the calibration experiments, and for each box of radiographic films a new sensitometric curve was measured. All radiographic films were processed using a Kodak X-Omat ME-3 film processor and digitized using a Konica KFDR-S film reader. After fitting the individual sensitometric curves using a third-order polynomial, the pixel readings of the radiographic films were converted into dose values.
The total number of MUs used for irradiating the anthropomorphic phantoms was adapted to exploit the dynamic range of the radiographic films as much as possible, while avoiding saturation effects. The experiments were repeated several times to assess the reproducibility, and to eliminate possible differences in the handling of the films ͑i.e., positioning, irradiating, developing and digitizing the films͒ and/or differences between various film batches. In total, 192 films were irradiated at the seven film positions. The reproducibility was calculated for each film position and treatment beam by first determining the average film dose and standard deviation of individual pixels and subsequently determining the average of the standard deviations over all pixels. If the average deviation between the dose distribution of a specific film and the mean dose distribution at that film position was larger than 3 times the standard deviation, that particular film measurement was considered to be an outlier and excluded from further analysis ͑ten films in total͒. The film dose distributions were normalized, applying a single normalization factor for all measured film dose distributions. To calculate this normalization factor, the ratio of the dose distributions obtained with film dosimetry and with Pinnacle was determined for all pixels and averaged for each film position. Subsequently, these averages obtained for all film positions were averaged for both phantoms, applying a weighing factor for the number of pixels at each film position. In this way, trends due to systematic errors originating from film dosimetry and/or the dose calculation algorithm may be identified ͑see the Appendix͒.
F. Comparison of dose distributions
The exact orientation of the films in a particular plane of the anthropomorphic phantoms is different in each measurement. In addition, the experimental and reconstructed dose distributions correspond to different planes and volumes. Therefore, the various dose distributions were geometrically matched, averaged and compared using 3-D matching software developed in our institution. 29 All matching was performed manually and the quality of the match was judged by eye. Alignment of the films with respect to each other and with respect to the CT data could be achieved straightforwardly, because the external contour of the anthropomorphic phantoms could easily be distinguished on individual films and the film positions were clearly visible in the CT data. The error resulting from misaligning film and CT data is estimated to be 2 mm at maximum for the irradiated part of the radiographic films.
The EPID and film dose distributions correspond to different planes, and can only be compared directly at the intersection of these planes. Therefore, we have first validated the calculations of the absolute and relative 3-D dose distribution with the results of ionization chamber and film dosimetry, respectively. The 3-D dose calculations were then used as reference values for evaluating the results of 2-D EPID dose determinations. In addition, the feasibility of 3-D portal dosimetry was tested, by comparing the reconstructed dose distributions in several planes with 3-D dose calculations obtained with Pinnacle. For comparing the reconstructed dose distributions with calculated 3-D dose distributions, the geometrical information of the planned setup of the treatment beams was used and the experimental error in aligning the phantoms was ignored.
For the quantitative analysis of the results, the lung region and the region with distances less than 2 cm from the skin were excluded.
III. RESULTS
The planned and experimental total dose distributions resulting from all treatment beams ͑Fig. 2͒ display dose gradients, which are commonly observed for the standard treatment technique for breast cancer patients. In the AP direction, a more or less homogeneous dose distribution was obtained by the application of a wedge to compensate for the variation of the breast contour. At the cranial and caudal parts of the breast and at the proximity of the lungs, however, regions with dose differences up to 10% relative to the prescribed dose were observed.
A. Validation of TPS calculations with ionization chamber and film dosimetry
The calculated dose and the dose measured at the isocenter of phantom B using an ionization chamber were equal to 150.0 cGy and 150.6Ϯ0.3 cGy ͑1 SD͒, respectively. The difference between these values was less than the tolerated output fluctuation of the treatment machine. The difference in isocenter position of the two phantoms resulted in a lower calculated dose for phantom A of 140.1 cGy at the isocenter. The dose distributions calculated with the TPS corresponded very well with the normalized total film dose distributions for both phantoms ͑Fig. 2͒. The difference between the calculated and measured film dose, averaged over all pixels, was Ϫ0.5%Ϯ1.3% ͑1 SD͒ and 0.2%Ϯ2.1% ͑1 SD͒ for phantoms A and B, respectively. In the Appendix it is shown that these deviations are consistent with the observed reproducibility of the film measurements.
B. Accuracy of 2-D dose reconstruction
If the attenuation correction was applied, the deviation between the reconstructed and planned total dose distributions resulting from all treatment beams is 0.3%Ϯ1.6% ͑1 SD͒ and Ϫ0.3%Ϯ1.8% ͑1 SD͒ for phantoms A and B, re- spectively ͓Table I, Figs. 3͑a͒, 3͑b͔͒. At the isocenter, the deviation between the reconstructed and planned total dose was smaller than 1% for both phantoms. The spatial distribution of these deviations, as plotted in Fig. 4 for phantom A, shows that the difference was less than 2% at the major part of the isocenter plane. At the cranial and caudal side of the isocenter plane, the deviations were larger ͑up to Ϫ2.5%͒ as well as in a small region toward the outer contour ͑up to ϩ1.5%͒. Only at the position of the lung and skin, the regions that have been excluded from quantitative analysis, this deviation increased up to ϩ10%. The spatial distribution of deviations in phantom B displayed the same trend. The deviation between the reconstructed and planned total dose averaged over all pixels of the isocenter plane of both phantoms was Ϫ0.1%Ϯ1.7% ͑1 SD͒. For the individual beams, the average deviation between the reconstructed and planned dose ranged from Ϫ3.6% to ϩ3.6% with standard deviations of about 2% ͓Table I, Fig. 3͑d͔͒ . If the combined dose of opposing beams was considered, the deviations are slightly smaller ͓Table I, Fig. 3͑f͔͒ .
If the attenuation correction was not applied, the accuracy of the dose reconstruction remained acceptable if the dose distributions of ͑nearly͒ opposing beam segments were combined. If the dose resulting from the sum of all individual beams, from the sum of the open, or from the sum of the wedged beams was reconstructed, the average deviations decreased by approximately 2% upon the application of the attenuation correction, while the error distributions were almost unchanged ͓Table I, Figs. 3͑a͒, 3͑b͒, 3͑e͒, 3͑f͔͒ . If the attenuation correction was not applied for dose reconstruction of the individual beams, the average deviation for these beams ranged from 0% to ϩ6%, with standard deviations up to 10% ͓Table I, Fig. 3͑c͔͒ .
Several trends can be observed if the results obtained for the individual beams are inspected in Table I . The error in the dose reconstructed from the portal images was systematically higher ͑more positive͒ for phantom A than for phantom B, which had less lung tissue within the irradiated volume. Furthermore, a comparison of the results for open and wedged beams shows that dose reconstruction for beams with wedges probably results in too low dose values ͓Figs. 3͑e͒, 3͑f͔͒. However, the largest improvement in the accuracy of dose reconstruction was obtained if the attenuation correction was applied or if only the contribution of opposing beams was considered. This effect was considerably larger than the influence of inhomogeneities or wedges on the results for this treatment technique.
C. Accuracy of 3-D dose reconstruction
In planes oriented parallel to the isocenter plane, the deviations between the reconstructed and planned dose were of the same order of magnitude, as observed for the isocenter plane ͑Fig. 5͒. Also in these planes, the deviation between the planned and reconstructed dose was most pronounced in regions that are closest to the skin. In particular, in planes located Ϯ8 cm from the isocenter, the deviations were significantly larger. The average deviation over all reconstruction planes within the irradiated volume, excluding the lung region and the region less than 2 cm from the skin, was 1.4%Ϯ5.4% ͑1 SD͒. For planes within 5 cm of the isocenter plane, the deviation was 0.5Ϯ3.4% ͑1 SD͒.
D. Accuracy of the dose-volume histogram
Our algorithm provides both the 2-D dose reconstruction at the isocenter plane, and a 3-D dose reconstruction of the irradiated volume. It seemed therefore worthwhile to compare reconstructed 2-D dose distributions, given as dosearea histograms ͑DAHs͒, with planned dose-volume histograms ͑DVHs͒. It can be seen ͓Figs. 6͑a͒-6͑c͔͒ that the accuracy of assessing the uniformity of the delivered dose was limited if 2-D dosimetry was performed, especially if no attenuation correction was applied. In that case, the dose in the irradiated volume was overestimated by using the corresponding DAH, compared to the cumulative dose-volume histogram of the 3-D dose distribution obtained with the TPS ͓Fig. 6͑a͔͒. Figure 6͑b͒ shows that some improvement was obtained by including contour information during 2-D dose reconstruction. However, even if the TPS is used, assessing the uniformity of the delivered dose in the irradiated volume by applying the DAH from a 2-D dose distribution instead of the complete DVH is obviously limited ͓Fig. 6͑c͔͒. Only if FIG. 4 . Error map of the reconstructed total dose distribution resulting from all treatment beams for phantom A. The black, hatched, gray, and white areas represent error levels of 0%-1%, 1%-2%, 2%-5%, and Ͼ5%, respectively. See also Fig. 5͑e͒. the true DVH was calculated from the nine reconstructed dose distributions presented above, a high accuracy could be obtained ͓Fig. 6͑d͔͒.
IV. DISCUSSION
A. Comparison of 3-D dose calculations and film dosimetry
A large number of contradicting results have been reported concerning the response of radiographic film obtained under various experimental conditions. 28, [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] Because the problems involved in applying film dosimetry for absolute dose determinations are beyond the scope of our present study, we decided to limit ourselves to relative film dosimetry. Under the application of an overall normalization factor, the observed deviations between the dose distributions obtained with film dosimetry and with the TPS did not show a trend with the orientation or depth of the radiographic films. Consequently, the effects of film orientation and/or the presence of air gaps as observed by Suchowerska et al. 40 have not introduced systematic errors in this study. However, the uncertainty in the positioning of the phantoms in combination with the steep change in film response with the angle of incidence of the photon beam at nearly parallel irradiation as observed by Suchowerska et al., 40 may have caused the somewhat reduced reproducibility of the results for phantom B. Because the 95% confidence interval of the measured film dose as calculated from the observed reproducibility ͑see the Appendix͒, is larger than the magnitude of the observed deviations between the measured and planned dose distributions, we may conclude that the deviations between the film and planned dose mainly originate from film dosimetry. In addition, we found that the deviations between ionization chamber measurements and calculations performed with the TPS are smaller than the output fluctuations of the accelerator. Therefore, we estimate that the error in the 3-D dose calculations obtained with the TPS are less than 1% ͑1 SD͒ over the volume of interest and that it is justified to use the 3-D calculations obtained with the TPS as a reference for our EPID dosimetry work. FIG. 5 . Deviations between the reconstructed dose ͑EPID͒ and the calculated dose ͑Pinnacle͒ in various planes that are oriented parallel to the isocenter plane for phantom A. ͓͑a͒, ͑b͒,...,͑h͒, ͑i͒ correspond to planes oriented at 8 cm, 6 cm,...,Ϫ6 cm, Ϫ8 cm medially from the isocenter plane.͔ The color scale indicates the magnitude of the observed deviations.
B. Accuracy of 2-D dose reconstruction at the midplane
One might argue that the dose reconstruction at the isocenter plane or radiological midplane ͑i.e., with or without using contour information͒ yields an equally valid representation of the patient dose and that the exact location of the reconstruction plane is not of clinical importance. However, the comparison of the reconstructed and planned dose can only be carried out if contour information is included and the two dose distributions correspond to the same plane. If the attenuation correction is applied, the average deviation between the reconstructed and planned total dose at the isocenter plane averaged over both phantoms is Ϫ0.1%Ϯ1.7% ͑1 SD͒. For the actual treatment of breast cancer patients, the amount of lung within the treatment beam, the external contour of each patient and the wedge angles will vary from patient to patient. To estimate the corresponding change in accuracy, the results for the individual beams as given in Table I can be analyzed. First, the average deviations observed for phantom A are approximately 3% higher ͑more positive͒ than those obtained for phantom B. In phantom B, the isocenter is located more to the apex of the breast, resulting in a negligible amount of lung tissue within the irradiated volume for phantom A. Therefore, the different results for phantoms A and B show that the contribution of scattered radiation to the dose in the target volume is overestimated by the reconstruction algorithm if lung tissue is present. Second, the deviations for the wedged beams are approximately 3% lower than those obtained for the open beams. Because the calibration constants and fit parameters for the dose reconstruction algorithm have been determined for open beams only, this effect is most likely related to beam hardening due to the application of wedges. Finally, the average deviations are approximately 3% lower if the attenuation correction is applied, showing the influence of the asymmetric external contour. These different effects cannot simply be combined, but the results obtained for a reconstruction of the total dose show that the overall effect is small if the attenuation correction is applied. Therefore, the same accuracy for 2-D dose reconstruction may be expected during the treatment of patients as observed in this study. If contour information is not available, the accuracy of dose reconstruction is only sufficient for ͑nearly͒ opposing beams. One should note, however, that larger errors may be expected if contours of the breast obtained during treatment planning are used, rather than contours obtained during treatment. The effect of anatomical changes during a complete series of treatment fractions on the dose estimation is under study.
C. Accuracy of 3-D dose reconstruction
The reconstruction of the dose in planes parallel to the isocenter plane yields surprisingly small deviations from the planned dose values, considering the fact that the same scatter kernel has been used to convolve the primary photon beam in each plane. Although the skin region itself has not been included in the analysis, the accuracy of dose reconstruction for breast patients with the algorithms presented in this work is mainly determined by the deviations occurring toward the skin. This is true, in particular, for 3-D dose reconstruction, since the region near the skin, which is included in the analysis, is relatively large. The experimental dataset, which is used to determine the parameters of the reconstruction algorithm, was obtained for phantoms with a thickness larger than 5 cm. Therefore, the PDD curve has most likely not been modeled properly for depths around the dose maximum. To improve the accuracy of dose reconstruction for these depths, a more dedicated fit parameter dataset is required. The applied model of the dependence of the reconstructed dose on phantom thickness ͑i.e., the NSPR͒ in the currently used algorithms is sufficiently flexible to manage an extended experimental dataset. An improved accuracy of the dose reconstruction at depths around the depth of dose maximum is part of our future work.
Within a distance of 5 cm from the isocenter plane, the average deviation between the reconstructed and planned dose is 0.5%Ϯ3.4% ͑1 SD͒. For a number of treatments other than the one considered in this study, the planning target volume lies within this volume. Also, the variation of the external contour is often much smaller and the target volume located farther away from the skin. Therefore, it is reasonable to expect that if contour variation or inhomogeneities are not important, the 3-D dose reconstruction will be more accurate than observed here. Still, a higher accuracy may be needed for future applications, e.g., for a 3-D dose verification of whole breast treatments. In those cases, appropriate scaling of the scatter kernels has to be applied. To obtain an extended dataset for scaling the scatter kernels, only a limited number of additional ionization chamber measurements in polystyrene slab phantoms would be involved for standard treatment configurations.
Although the DVHs presented in this study are calculated using a relatively simple algorithm that may be further refined, a reasonably accurate estimate of the dose homogeneity in the irradiated volume is obtained if a 3-D dose reconstruction is applied ͓Fig. 6͑d͔͒.
D. Patient scatter to the image
An assumption in the original dose reconstruction algorithm, which may not be completely justified for EPID dosimetry during breast cancer treatment, concerns the scatter from the patient reaching the EPID. It has been shown that this scatter contribution is small and homogeneously distributed if the distance between the patient and portal imager is large ͑e.g., during prostate treatments͒. 5 In those cases, the contribution of patient scatter to the portal dose can be approximated using a simple proportionality between this scatter contribution and the uncorrected transmission of the irradiated volume. For the treatment of breast cancer patients, however, the distance between patient and portal imager has to be reduced to enable imaging of the large treatment fields. This reduced air gap may lead to a larger and nonuniform scatter contribution from the patient to the EPID and may deteriorate the accuracy of the dose reconstruction algorithm. Several investigators have studied this phenomenon and have proposed alternative methods to calculate the scatter contribution of the patient to the portal imager. [41] [42] [43] [44] [45] In our approach, the scatter distribution at the position of the EPID is assumed to be uniform. Furthermore, for the phantom measurements we found that the scatter to primary ratio ͑SPR͒ is only 2.5%, which is in line with former values for this beam energy and field size. 41 Thus, the patient scatter correction effectively contributes 2.5% to the total dose at the isocenter plane if we ignore its influence on the NSPR at that plane. The latter approximation is valid because it is a second-order effect only. The error in the reconstructed 2-D dose reconstruction would therefore increase by 0.25%, at most, if the error in the calculation of the patient scatter would be as high as 10%. Given the applied beam qualities, the thickness of the irradiated volumes, and the size of the largest field sizes that may be applied clinically for breast cancer treatment, we estimate that the SPR at the position of the EPID will always be less than 10%. 41 Even if that would be the case and maintaining the previously assumed error level of 10%, the error in the reconstructed 2-D dose would only be 1% higher compared to the application of an exact calculation of the patient to EPID scatter contribution. Therefore, we conclude that the simple algorithm to estimate the patient scatter to the imager, as applied in our approach, suffices in practical applications. As an additional test, we implemented an extended algorithm, which improved the accuracy of the calculation of the scatter contribution by several percent for large field sizes. This extended algorithm includes an iterative loop similar to the routine described by Hansen et al., 41 although measured beam data were used as input in our approach. The results of dose reconstruction changed less than 0.5% for the experiments presented in this work, and the extended algorithm was not applied in the analysis.
E. Comparison with other 3-D dose reconstruction methods
Several authors have presented methods for a 3-D reconstruction of the patient dose using CT data, which are representative for the patient anatomy during treatment. In the concept originally presented by McNutt et al., 2, 3 an iterative convolution/superposition method was used to determine the primary energy fluence and subsequently the patient dose applying predefined scatter kernels. Partridge et al. 10 also apply an iterative method to determine the primary energy fluence, but propose either the application of the original TPS or an independent algorithm ͑e.g., Monte Carlo planning calculation͒ to reconstruct the patient dose. Both methods require a more sophisticated algorithm to determine the primary fluence and patient dose, and/or a low-level access to the TPS, and rely on the validity of the CT data. On-line CT data are currently not available in many institutions, however, and will most likely only be available in a limited number of treatment centers ͑and obtained for a limited number of patients͒ in the near future. The relatively simple method we present in this study is therefore especially useful when CT data, whether on-line or not, are not available.
F. Clinical factors influencing the accuracy of dose reconstruction
During actual patient treatments, positioning errors may influence the accuracy of the dose reconstruction. When appropriate 3-D setup verification and correction procedures are applied, patient-positioning errors can generally be minimized to a few mm, 46 in which case the accuracy of dose reconstruction will be within the previously specified range. Setup verification and correction of patient positioning is generally not performed for the treatment of breast cancer patients with the tangential field technique, however. Although the reconstructed patient dose will still represent the dose actually delivered to the irradiated volume if patient positioning errors occur, a determination of the coverage of the target volume and of the dose to organs at risk requires an independent analysis.
If contour information is used to reconstruct the dose, patient positioning errors along the axis of the treatment beam will yield an opposite effect for the medial and lateral beams and will cancel out in the total dose per fraction. Patient positioning errors, perpendicular to the beam axis, can first be corrected by matching the portal images to the available reference images ͑simulator images or DRRs͒. Next, contours can be shifted accordingly prior to dose reconstruction. Although the accuracy of a 2-D correction on the 3-D setup error will be limited, we estimate that the influence of the remaining setup error on the accuracy of the dose reconstruction is negligible because it will be a secondorder effect only ͑the attenuation correction is the first-order effect on the accuracy of dose reconstruction͒.
Because the heart was not simulated in these phantoms, the accuracy of reconstructing the heart dose during breast cancer treatment could not be assessed. Considering the position of the heart within the lung region, the radiological midplane will be located more closely to the central plane of the heart than the isocenter plane. Therefore, it may be expected that reconstruction of the heart dose in the radiological midplane ͑when contour information is not used͒ will yield a more accurate representation of the heart dose than the dose in the isocenter plane. The use of the EPID for the verification of heart dose during patient treatment is the topic of further study.
During the initial phase of this study, we observed that the EPID response varied considerably with time. By applying a thorough QA procedure, including regular recalibration of the EPID, the high accuracy of dose reconstruction as reported in this paper could be obtained. The study of the long-term stability of the EPID will be dealt with in a separate paper.
V. CONCLUSIONS
We have extended a previously developed algorithm to reconstruct the patient dose in the isocenter plane, specifically for the treatment of breast cancer patients. A simple attenuation correction is used based on the external contour of the patient. In addition to a more accurate 2-D dose reconstruction in the isocenter plane, we have shown that now also a reasonably accurate 3-D dose reconstruction is possible in planes within 5 cm from the isocenter plane using the extended dose reconstruction algorithm. The largest errors result from limitations of our algorithm in the presence of inhomogeneities ͑lungs͒ and at depths around the dose maximum ͑skin͒. Furthermore, we have shown that 3-D dose reconstruction yields accurate values of the DVH of the irradiated volume, thus allowing the in vivo verification of the dose delivery to the irradiated volume. The uncertainty in the contribution of patient scatter to the imager has only a limited effect on the accuracy of dose reconstruction, and a crude estimate of this quantity is sufficient for most applications.
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APPENDIX: ACCURACY OF TPS CALCULATIONS
The contribution of random noise in the film dose determinations to the observed differences between the planned and film dose distributions was estimated from the observed reproducibility of film dose measurements. Because the variations in film dose were approximately normally distributed at all film positions ͑data not shown͒, these variations were treated as random noise. For each film position, the total dose was calculated by averaging and adding the dose distributions of the individual beams. The final noise level for the total film dose distribution at a particular film position was calculated accordingly. First, the standard error of the mean, SEM i j , was calculated at each pixel position. These numbers were subsequently averaged for each film position P and for each treatment beam B to determine their contribution to the overall noise level of film dosimetry, SEM BP ͑Table II͒:
in which i j , n i j , and N BP represent the standard deviation and the number of pixels at a specific film position, and the number of film measurements, respectively. The noise level of the total film dose was then calculated for each film position by quadratically summing the SEM of the individual beams:
For phantom A, the overall noise level was 1.3% ͑SEM͒. Three films ͑out of 72͒ were marked as outlier and excluded from further analysis. For phantom B, an overall noise level of 2.1% ͑SEM͒ was obtained, while 7 films ͑out of 120͒ were marked as an outlier. At each film position, the observed deviations between the planned and measured dose lie within the 95% confidence interval ͑Ϯ1.96ϫSEM͒ of the total film dose ͑Table II͒. Furthermore, the deviations in Table II 
